Weitere Publikationen
Weitere unterstützte Publikationen
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
C. Michael Gibson, M.D., P. Gabriel Steg, M.D., M. Cecilia Bahit, M.D., Rasha Al-Lamee, M.B., B.S., Ph.D., Shamir R. Mehta, M.D., Roxana Mehran, M.D., Jeffrey I. Weitz, M.D., Shinya Goto, M.D., Ph.D., Jose Carlos Nicolau, M.D., Ph.D., Renato D. Lopes, M.D., Ph.D., Junbo Ge, M.D., Nebojsa Tasic, M.D., Ph.D., Dominick J. Angiolillo, M.D., Ph.D., Suzanne J. Baron, M.D., Ajay J. Kirtane, M.D., Denis Xavier, M.D., Satoshi Yasuda, M.D., Ph.D., Basil S. Lewis, M.D., Duk-Woo Park, M.D., Ph.D., Jan H. Cornel, M.D., Ph.D., Thomas W. Johnson, M.D., Jaroslaw Trebacz, M.D., Daniel Duerschmied, M.D., Christoph Bode, M.D., Ph.D., Bela Merkely, M.D., Ph.D., D.Sc., Maria Dorobantu, M.D., Ph.D., Dragos Vinereanu, M.D., Ph.D., Zuzana Motovska, M.D., Ph.D., Hector Bueno, M.D., Ph.D., Jose Luis Lopez-Sendon, M.D., Gregory Ducrocq, M.D., Ph.D., Giuseppe Ambrosio, M.D., Ph.D., Lesley Burgess, M.B., Ch.B., Ph.D., Allan Bohm, M.D., Ph.D., Chern-En Chiang, M.D., Ph.D., Joao Morais, M.D., Alan Fong, M.D., Umit Guray, M.D., Jose Luis Leiva-Pons, M.D., Pascal Vranckx, M.D., Ph.D., Harvey D. White, D.Sc., Sasko Kedev, M.D., Ph.D., Marco Valgimigli, M.D., Ph.D., Duško Cerovec, M.D., Ph.D., Dimitris Tousoulis, M.D., Ph.D., Gemma Figtree, M.B., B.S., D.Phil., Thuong Dung Ho, M.D., Ph.D., Rody G. Sy, M.D., Morten Bøttcher, M.D., Ph.D., Kurt Huber, M.D., Rimvydas Slapikas, M.D., Ph.D., Andrejs Erglis, M.D., Ph.D., Jack Wei Chieh Tan, M.B., B.S., Christian Pincetti, M.D., Karen S. Pieper, M.S., Kenneth W. Mahaffey, M.D., Carolyn S.P. Lam, M.B., B.S., Ph.D., S. Claiborne Johnston, M.D., Ph.D., Graeme J. Hankey, M.B., B.S., M.D., Jennifer S. Li, M.D., Luke Zheng, Ph.D., Ronald Aronson, M.D., Danshi Li, M.D., Ph.D., Ravi Notani, M.B.A., Philippe Vieira Pires, M.D., Thomas J. Povsic, M.D., Alistair C. Lindsay, M.D., Alexei Plotnikov, M.D., Ph.D., Hsiaowei Deng, M.S., Elliot S. Barnathan, M.D., and Robert A. Harrington, M.D., for the LIBREXIA ACS Committees and Investigators
Accepted 8/2026 New England Journal of Medicine
Clinical practice of cangrelor use in Austrian ACS patients: a real-world multicenter registry
Christoph Beyer , Matthias Frick, Gabor Toth-Gayor, Hannes Alber, Jolanta Siller-Matula, Günter Christ, Gerald Zenker, Kurt Huber, Raphael Wilfing, Herwig Schuchlenz , Fabian Plank and Guy Friedrich
Accepted 8/2026 Frontiers in Cardiovascular (MPUB affiliation)
Early Hemolysis, Myolysis and Renal Stress Following Pulsed Field Versus Radiofrequency Ablation of Atrial Fibrillation
Paul Felix Harbich, Lisa Auer, Florian Tinhofer, Achim Leo Burger, Tobias Eberl, Patrick Weltler, Stephan Dobner, Alexander Geppert, Kurt Huber, Christoph Clemens Kaufmann
Accepted 8/2026 European Journal of Clinical Investigation (MPUB affiliation)
Considerations for Criteria for the Diagnosis of Cardiogenic Shock: An European Perspective.A Clinical Consensus Statement of the European Association for Acute CardioVascular Care (ACVC), the Heart Failure Association (HFA) and the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Hoong Sern Lim1, Agnieszka Tycinska2, Clement Delmas3, Jacob Eifer Moller4, Janine Pöss5, Christian Stoppe6, Christophe Vandenbriele7, Holger Thiele5, Kurt Huber8, Ingo Ahrens9, Christian Hassager10, Ovidiu Chioncel11, Marco Metra12,13, Matteo Pagnesi14, Wiktor Kuliczkowski15, Maja Cikes16, Linda W. van Laake17, Alessandro Sionis18, Mario Iannaccone19, Stephane Manzo-Silberman20, Federico Pappalardo21, Susanna Price22, Thomas F Lüscher23-26, Benedikt Schrage27
Accepted 8/2026 European Heart Journal – Acute Cardiovascular Care (MPUB affiliation)
Inflammation in coronary syndromes in clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the ESC Council on Basic Cardiovascular Science and the Council for Cardiology Practice. Short title: Inflammation in coronary syndromes in clinical practice
Roubille F, Kharlamov JA, Lenz M, Maonna R, Delmas C, Schaubroeck H, Morosin M, Wojta J, Vandenbriele C, Kerneis M, Lazaros G, Evans P, Huber K, Hassager C, Tsaban G, Heymans S, Christodorescu RM, Imazio M, Sionis A.
Accepted 6/2026 European Heart Journal – Acute Cardiovascular Care (MPUB affiliation)
Proteomics profiling for cardiovascular risk prediction: transforming clinical care
Isabella Kardys, Manuel Mayr, Johannes Mair, Nicholas L. Mills, Kurt Huber; on behalf oft he Study Group on Biomarkers of the ESC Association of Acute Cardiovascula Care
Accepted 5/2026 European Heart Journal – Acute Cardiovascular Care (MPUB affiliation)
Diagnostic challenges in isolated cardiac sarcoidosis
Tersalvi G, Rossi VA, Hundertmark M, Beltrani V, Escher F, Wörgötter K, Dobner S, Thianich FC, Treglia G, Schultheiss H, Huber K, Martinelli M, Pölzl G, Rosenbaum AN, AbouEzzeddine OF, Grübler MR.
Accepted 5/2026 European Journal of Heart Failure (MPUB affiliation)
Ventricular free-wall rupture, ventricular pseudoaneurysm and papillary muscle rupture complicating acute myocardial infarction. A Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the European Association of Preventive Cardiology (EAPC) of the ESC, the Heart Failure Association (HFA) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC, and the European Association of Cardio-Thoracic Surgery (EACTS)
Roberto Lorusso,1,2 Matteo Matteucci,1,3 Daniele Ronco,1,4 Giulio Massimi,1,5 Susanna Price,6,7 Martin Czerny,8,9 Rodrigo Estévez-Loureiro,10 Matthias Siepe,11 Gianluca Pontone,12,13 Christian Hassager,14 Ovidiu Chioncel,15 Marco Zuin,16 Constantinos H. Davos,17 Marianna Adamo,18 Finn Gustafsson,19 George Giannakoulas,20 Nicolas Amabile,21 Alessandro Sionis,22,23 Matthias Thielmann,24 Steffen Erhard Petersen,25,26 Bernard Cosyns,27 Kurt Huber,28 Mariya Tokmakova,29 Davide Pacini,30 Frederikus A. Klok,31 Francesco Saia,32 Ana Abreu,33 Michael Grimm,34 Marc J. Claeys,35 Ana García Álvarez,23,36 Bernhard Gerber,37 Carlos A. Mestres,38 Stephan Rosenkranz,39,40 Stamatis Adamopoulos,41 Nikolaos Bonaros.42
Accepted 5/2026 European Journal of Cardio-Thoracic Surgery (MPUB affiliation)
Functionality as a Coping Mechanism: A Deep Hermeneutic Interpretation of the Burdens Encountered by Healthcare Workers During the COVID-19 Pandemic
Schiller B, Grüner M, Wimmer E, Reisinger M, Wagner I, Fiegl J, Eichenberg C, Huber K, Brunner M, Mörtl K.
Accepted 2/2026 Internatioal Journal of Qualitative Studies on Health and Well-being
The Safety of Low Lipoprotein(a) Concentration: Insights from the FOURIER Trial
Gencer B, Giugliano RP, Ran X, Mach F, Stroes ESG, Gouni-Berthold I, Ceska R, Ezhov MV, Jukema W, Jensen HK, Tokgözoglu SL, Huber K, Im K, Sabatine MS, O’Donoghue ML.
Accepted 3/2026 European Heart Journal (MPUB affiliation)
Beyond Cardiac Index: Is it Time to Think Outside of The Box in Cardiogenic Shock?
Araiza-Garaygordobil, Preciado-Anaya OU, Mena LiHG, Alviar CL, Huber K.
Accepted 3/2026 Current Reviews in Cardiology (MPUB affiliation)
Update on Acute Mechanical Circulatory Support including Percutaneous Ventricular Assist Device in Cardiogenic Shock. A Clinical Consensus Statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute CardioVascular Care (ACVC) of the ESC
Chieffo A, Iannaccone M, Hassager C, Dudek D, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller J, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, Van Mieghem NM, Vrancky P, Desch S, Werner N, Price S.
Accepted 3/2026 European Heart Journal (MPUB affiliation)
Ask The Expert: 10 Jahre Repatha® kardioaskuläres Risiko effektiv reduzieren
G. Friedrich, K. Krychtiuk, K. Huber, Y. Winhofer, C. Weiser.
Accepted 3/2026 Kardiologie (MedAhead) (MPUB affiliation) (kein IF)
Comparison of a combined strategy of cardiovascular biomarkers and phonocardiography with the 2024 ESC Risk-Factor-weighted Clinical Likelihood model to diagnose coronary artery disease
Marie Muthspiel1,4, Moritz Hebein1, Christoph C. Kaufmann1,4, Achim Leo Burger1,4, Amro Ahmed1, Ben Panzer1, Philipp Hohensinner2,3, Johann Wojta2,3, Kurt Huber1,3,4, Alexander Geppert1, Bernhard Jäger1,3,4
Accepted 2/2026 European Heart Journal – Imaging Methods and Practice (MPUB affiliation)
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with acute myocardial infarction: A pre-specified subgroup analysis of the randomized MULTISTARS-AMI trial
Miklos Rohla1, MD, PhD; Kurt Huber2,3, MD; Ferdinando Varbella4, MD; Axel Linke5, MD; Bettina Schwarz6, MD; Stephan B. Felix7, MD; Moritz Seiffert8, MD; Rahel Kesterke9, PhD; Peter Nordbeck10, MD; Bernhard Witzenbichler11, MD; Irene M. Lang12, MD; Mirjam Kessler13, MD; Christian Valina14, MD; Alban Dibra15, MD; Philipp Jakob9, MD; Marco Moccetti16, MD; Matteo Vercellino17, MD; Luise Gaede18, MD; Lorenz Bott-Flügel19, MD; Julia Stehli9, MD, PhD; Alessandro Candreva9, MD; Francesco Paneni9, MD; Christian Templin9, MD, PhD; Matthias Schindler9, PhD; Manfred Wischnewsky20, PhD; Greca Zanda4, MD; Giorgio Quadri4, MD; Norman Mangner5, MD; Aurel Toma12, MD; Giulia Magnani21, MD, PhD; Peter Clemmensen22, MD; Thomas F. Lüscher23; MD; Thomas Münzel24, MD; P. Christian Schulze25, MD; Karl-Ludwig Laugwitz26, MD; Wolfgang Rottbauer13, MD; Franz-Josef Neumann14, MD; Steffen Schneider27, PhD; Thomas Riemer27, PhD; Franz Weidinger28, MD; Stephan Achenbach18, MD; Gert Richardt6, MD; Adnan Kastrati29, MD; Ian Ford30, PhD; Frank Ruschitzka9, MD; Barbara E. Stähli9, for the MULTISTARS AMI Investigators
Accepted 2/2026 Clinical Research in Cardiology (CRCD) (MPUB affiliation)
Management of dyslipidaemia in patients with comorbidities – facing the challenge: Heart failure Heinz Drexel 1,2,3,4, Matthias Frick 5, Andreas Zirlik 6, Alexander Niessner 7,8, Kurt Huber 9, Juan Tamargo 10, Bianca Rocca 11, Dobromir Dobrev 12,13,14, Arthur Mader 1,5, Stefan Agewall 15
Accepted 2/2026 European Heart Journal – Cardiovascular Pharmacology (MPUB affiliation)
Transcatheter aortic valve thrombosis
Jacobsen MR, Overduin D, Sørensen R, Andreotti F, Schulte C, Huber K, Clemmensen P, Trenk D, Backer OD, Aradi D, Kristensen SD, Storey R, ten Berg JM, Geisler T.
EuroIntervention; 2026 (PUB affiliation)
A dual biomarker strategy improves triaging of patients with suspected acute coronary syndrome – Pro a dual biomarker strategy. Giannitsis E, Blankenberg S, Huber K, Möckel M, Schröder M, Hamm CW.
Accepted 1/2026 European Heart Journal (MPUB affiliation)
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention – options for personalisation to reduce bleeding or ischaemic risks. A Clinical Consensus Document led by the ESC Working Group on Thrombosis together with the Association for Acute Cardiovascular Care, the European Association of Percutaneous Cardiovascular Interventions and the ESC Working Group on Cardiovascular Pharmacology
Gorog DA, Rubboli A, Gigante B, Storey R, Lip G, ten Berg J, Valgimigli M, Halvorsen S, Navarese E, Geisler T, Vandenbriele C, Siller-Matula J, Huber K, Jeong YH, Ahrens I.
Accepted 12/2025 European Heart Journal – Acute Cardiovascular Care (MPUB affiliation)